Carbon monoxide ( DrugBank: Carbon, Carbon monoxide )

---

2 diseases

ID	Disease name (Link within this page)	Number of trials
85	Idiopathic interstitial pneumonia	1
86	Pulmonary arterial hypertension	1

85. Idiopathic interstitial pneumonia

---

Clinical trials : 627 /  Drugs : 443 - (DrugBank : 120) / Drug target genes : 99 - Drug target pathways : 212

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01214187 (ClinicalTrials.gov)	July 2011	30/9/2010	Study of Inhaled Carbon Monoxide to Treat Idiopathic Pulmonary Fibrosis	Phase II Study of Inhaled CO for the Treatment of Idiopathic Pulmonary Fibrosis	Idiopathic Pulmonary Fibrosis	Drug: inhaled carbon monoxide;Other: Oxygen	Brigham and Women's Hospital	National Heart, Lung, and Blood Institute (NHLBI);University of California, San Francisco;University of Chicago;University of Illinois at Chicago;University of Michigan;Columbia University;Tulane University;University of Washington	Completed	18 Years	85 Years	All	58	Phase 2	United States

86. Pulmonary arterial hypertension

---

Clinical trials : 1,205 /  Drugs : 684 - (DrugBank : 124) / Drug target genes : 100 - Drug target pathways : 193

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01523548 (ClinicalTrials.gov)	July 2012	27/1/2012	Carbon Monoxide Therapy for Severe Pulmonary Arterial Hypertension	Carbon Monoxide Therapy for Severe Pulmonary Arterial Hypertension	Hypertension, Pulmonary	Drug: Carbon Monoxide	University of Illinois at Chicago	National Institutes of Health (NIH);National Heart, Lung, and Blood Institute (NHLBI)	Withdrawn	18 Years	N/A	All	0	Phase 1/Phase 2	United States